Novosti
Khirurgii
This journal is
indexed in Scopus



Year 2010 Vol. 18 No 3

GENERAL AND SPECIAL SURGERY

SHEVELA A.I., EGOROV V.A., SEVOSTYANOVA K.S., NOVIKOVA YA.V., FILIPENKO M.L.

GENETIC RISK FACTORS OF VENOUS THROMBOSIS

Objectives. To determine the distribution of prothrombotic polymorphisms in patients with venous thrombosis in comparison with the control group and in different groups of patients with thromboses of inferior vena cava.
Methods. 43 patients without venous thrombosis in the anamnesis were investigated as well as 169 patients with phlebothrombosis of the lower limbs, divided into groups according to the age and the cause of the disease. The genes of plasma, platelet hemostasis factors, folate cycle enzymes were studied.
Results. The effects of polymorphism genes V factor of coagulation, methylenetetrahydrofolate reductase, tissue plasminogen activator, VII coagulation factor and fibrinogen on the development of thrombosis, particularly early and idiopathic were reliably revealed.
Conclusion. The risk of venous thrombosis development is increased not so much by general number of involved genes, but by single polymorphisms having reliable influence on the development of the given disease. Correction of the conservative therapy in patients with the developed phlebothrombosis is possible on the ground of gene-typing as well as preventive methods in the patients of risk group.

Keywords: thrombophilia, coagulation factors, polymorphism, venous thrombosis, gene
p. 58 – 65 of the original issue
References
  1. Kamphuisen, P. W. Thrombophilia screening: a matter of debate / P. W. Kamphuisen, F. R. Rosendaal // Neth. J. Med. – 2004. – Vol. 62. – P. 180-187.
  2. Флебология: руководство для врачей / В. С. Савельев [и др.]; под ред. В. С. Савельева. – М.: Медицина, 2001. – 664 с.
  3. Котельников, М. В. Ведение больных с венозными тромбоэмболиями / М. В. Котельников. – М., 2006. – 102 c.
  4. Thrombophilia as a multigenic disease / B. Zoller [et al.] // Haematologica. – 1999. – Vol. 84, N 1. – P. 59-70.
  5. Rosendaal, F. R. Heritability of clotting factors and the revival of the prothrombotic state / F. R. Rosendaal, E. G. Bovill // Lancet. – 2002. – Vol. 359. – P. 638-639.
  6. Seligsohn, U. Genetic Susceptibility to Venous Thrombosis / U. Seligsohn, A. Lubetsky // The new England Journal of Medicine. – 2001. – Vol. 16, N 344. – P. 1222-1231.
  7. Tripodi, A. Issues concerning the laboratory investigation of inherited thrombophilia / A. Tripodi // Mol. Diagn. – 2005. – Vol. 9, N 4. – P. 181-186.
  8. Green, D. Genetic hypercoagulability: screening should be an informed choice / D. Green // Blood. – 2005. – Vol. 98, N 1. – P. 20.
  9. Baglin, T. Management of thrombophilia: who to screen? / T. Baglin // Pathophysiol. Haemost. Thromb. – 2003. – Vol. 33. – P. 401-404.
  10. Rosendaal, F. R. Venous thrombosis: a multicausal disease / F. R. Rosendaal // Lancet. – 1999. – Vol. 353. – P. 1167-1173.
  11. Mannucio Mannnuci, P. Genetic gipe-rcoagulability: prevention suggests testing family members / P. Mannucio Mannnuci // Blood. – 2006. – Vol. 98, N 1. – P. 21-22.
  12. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) stud / O. Wu [et al.] // Health Technol. Assess. – 2006. – Vol. 10, N 11. – P. 1-110.
  13. Маниатис, Т. Молекулярное клонирование / Т. Маниатис, Э. Фрич, Дж. Сэмбрук. – М.: Мир, 1984. – 480 c.
  14. Гланц, С. Медико-биологическая статистика / С. Гланц. – М.: Практика, 1999. – 462 c.
Contacts | ©Vitebsk State Medical University, 2007